Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Proteins|September 2, 2004
Comparative evaluation of eight docking tools for docking and virtual screening accuracyEsther Kellenberger, Jordi Rodrigo, Pascal Muller, et al.Proteins|November 19, 2005
A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptorsJean-Sebastien Surgand, Jordi Rodrigo, Esther Kellenberger, et al.Journal of Agricultural and Food Chemistry|September 16, 2010
Binding modes of noncompetitive GABA-channel blockers revisited using engineered affinity-labeling reactions combined with new docking studiesSébastien Charon, Antoine Taly, Jordi Rodrigo, et al.Bioorganic & Medicinal Chemistry Letters|April 6, 2010
Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinaseFaten Sliman, Mélina Blairvacq, Emilie Durieu, et al.Journal of Medicinal Chemistry|January 29, 2010
Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonistMarie-Céline Frantz, Jordi Rodrigo, Laure Boudier, et al.Molecular Pharmacology|November 5, 2005
Probing the reorganization of the nicotinic acetylcholine receptor during desensitization by time-resolved covalent labeling using [3H]AC5, a photoactivatable agonistAlexandre Mourot, Jordi Rodrigo, Florence Kotzyba-Hibert, et al.Analytical and Bioanalytical Chemistry|February 22, 2011
Hexylacrylate-based mixed-mode monolith, a stationary phase for the nano-HPLC separation of structurally related enkephalinsAyat Abbood, Christine Herrenknecht, Gaëlle Proczek, et al.Molecular Endocrinology (Baltimore, Md.)|November 4, 2006
Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptorsJordi Rodrigo, Ana Pena, Brigitte Murat, et al.Chemical & Pharmaceutical Bulletin|March 26, 2002
Influence of pH on the binding of diphenylmethylenepiperidines by 5-HT2B receptors in rat stomach fundusMaría-Angeles Honrubia, Jordi Rodrigo, María-Isabel Cadavid, et al.Proteins|April 15, 2008
Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore modelElodie Lescot, Jana Sopkova-de Oliveira Santos, Nathalie Colloc'h, et al.Pageof 3